abstract |
The invention provides new agonist compounds of the adrenergic receptor 32. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with the activity of the adrenergic receptor 2, and processes and intermediates useful for preparing such compounds. |